- Analytics
- Market Historical Data
- Stocks Historical Prices
- ALEXION-PHARMACEUTICALS
Alexion Pharmaceuticals Inc. Stock Price History
Alexion Pharmaceuticals Inc. Historical Data
You can see 24 days of Alexion Pharmaceuticals Inc. stock price history to determine the stock opening price for each day, i.e. the price at which the stock first trades at the opening of the exchange on the trading day, the highest price of the day is the highest price traded during that period, and the lowest price is the lowest price traded during that period and the closing price, i.e. the last price at which Alexion Pharmaceuticals Inc. stock trades during a normal trading session. In the last column of the table you will see the percentage change - the ratio of today's closing price to the previous one.
About Alexion Pharmaceuticals Inc. Stocks
Alexion Pharmaceuticals Inc. is a biopharmaceutical company. The company was founded in 1992 and is headquartered in Boston, Massachusetts. The Company is focused on the development and commercialization of therapeutic products. The Company's products include Soliris (eculizumab), Strensiq (asfotase alfa) and Kanuma (sebelipase alfa). The Company's clinical development programs include Soliris (eculizumab), cPMP (ALXN1101), SBC-103, ALXN1210 (IV) and ALXN1210 (Subcutaneous). Its Soliris is the therapeutic approved for patients with either paroxysmal nocturnal hemoglobinuria (PNH) or hemolytic uremic syndrome (aHUS). PNH and aHUS result from chronic uncontrolled activation of the complement component of the immune system. Its Strensiq is for the treatment of patients with Hypophosphatasia (HPP). Its product, Kanuma is for the treatment of patients with Lysosomal Acid Lipase Deficiency (LAL-D). It is a recombinant form of the human LAL enzyme, which is a replacement therapy that is approved for the treatment for patients with LAL-D.